4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-000096
Chief Executive Officer gave up 2,209 shares (to pay taxes)
- Chief Executive Officer acquired 4,895 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Robinson Chandler · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-31 | Exercise or conversion : show line 1 in the form | +4,895 | 61,057 | D | ||
| 2024-12-31 | Shares withheld for taxes : show line 2 in the form | −2,209 | $22.00 | $48,598 | 58,848 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-31 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −4,895 | 24,879 | D |
Loading xslF345X05/rdgdoc.xml…